<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Varela, Aimilia</style></author><author><style face="normal" font="default" size="100%">Mavroidis, Manolis</style></author><author><style face="normal" font="default" size="100%">Katsimpoulas, Michalis</style></author><author><style face="normal" font="default" size="100%">Sfiroera, Irini</style></author><author><style face="normal" font="default" size="100%">Kappa, Niki</style></author><author><style face="normal" font="default" size="100%">Mesa, Angelica</style></author><author><style face="normal" font="default" size="100%">Kostomitsopoulos, Nikolaos G</style></author><author><style face="normal" font="default" size="100%">Cokkinos, Dennis V</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The neuroprotective agent Rasagiline mesylate attenuates cardiac remodeling after experimental myocardial infarction</style></title><secondary-title><style face="normal" font="default" size="100%">ESC heart failure</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2017</style></year></dates><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">4</style></volume><pages><style face="normal" font="default" size="100%">331–340</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>